Royal Philips to Acquire BioTelemetry, Inc. for $2.8B

Royal Philips Acquires Capsule Technologies from Francisco Partners for $635M

January 19, 2021

Medical Devices

Royal Philips agreed to acquire Capsule Technologies, a portfolio company of Francisco Partners, for $635 million in cash. The deal will fold Capsule — a developer of medical device integration, patient monitoring, and clinical surveillance software used by hospitals worldwide — into Philips' Connected Care segment; Capsule has roughly 300 employees and serves more than 2,800 hospitals in 40 countries.

Philips Acquires Analytical Informatics, Inc.

November 24, 2017

Healthcare Services

Royal Philips has acquired US-based startup Analytical Informatics, Inc. to integrate the company's vendor-agnostic radiology workflow and analytics tools into Philips' PerformanceBridge radiology portfolio. The acquisition is intended to accelerate Philips' roadmap for Radiology Solutions by expanding operational intelligence, workflow optimization and data-driven decision support for imaging departments and enterprise customers; financial terms were not disclosed.

Philips Acquires Intact Vascular

August 27, 2020

Medical Devices

Royal Philips has signed an agreement to acquire Intact Vascular, a U.S.-based developer of the Tack Endovascular System, to expand Philips' image-guided therapy devices portfolio for peripheral artery disease. The deal includes USD 275 million upfront in cash plus deferred payments (up to ~USD 360 million total) and is expected to close in the third quarter of 2020, after which Intact Vascular will join Philips' Image-Guided Therapy business.

Emergency Care Holdings Acquires Philips Emergency Care Business (Heartstream)

January 14, 2026

Medical Devices

Emergency Care Holdings (ECH), a platform backed by Bridgefield Capital, completed the acquisition of the Philips Emergency Care business from Koninklijke Philips N.V., which will operate as Heartstream under a Philips brand license. The carve-out, headquartered in Bothell, Washington, employs more than 600 people, serves over 130 countries and positions ECH to launch a global emergency medical products platform focused on consolidation, innovation and recurring software and service revenue.

Johnson & Johnson Acquires Abiomed

December 22, 2022

Medical Devices

Johnson & Johnson completed its acquisition of Abiomed on December 22, 2022, acquiring all outstanding shares for $380.00 per share (approximately $16.6 billion enterprise value) plus a contingent value right. Abiomed will operate as a standalone business within Johnson & Johnson's MedTech segment, expanding J&J's capabilities in high-growth cardiovascular and heart-recovery solutions.

SD Biosensor and SJL Partners Acquire Meridian Bioscience for $1.53B

July 7, 2022

Medical Devices

A consortium led by SD Biosensor and private equity firm SJL Partners agreed to acquire Meridian Bioscience in an all-cash transaction valued at approximately $1.53 billion ( $34.00 per share). The deal will take Meridian private and is intended to accelerate SD Biosensor's entry into the U.S. in-vitro diagnostics market while leveraging Meridian's U.S. distribution network and product portfolio.